Release Date: 27/04/18 12:21 Summary: Notice of Annual General Meeting Price Sensitive: No Download Document 723.67KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%